Joe Rogan Experience #2578 - Calley Means · Aired Nov 6, 2026
Claim summary · not a verbatim quotation
Food companies are legally responsible for having studies showing that the amount of sugar they recommend for daily use for children does not harm them.
The finding
What the evidence shows
FDA itself has affirmed sucrose, ordinary cane or beet sugar, as generally recognized as safe by regulation. The rule allows it in food with no limit other than good manufacturing practice. Because the government already made that safety finding, food companies have no legal duty to hold studies showing that the amount of sugar in children's products, or a recommended daily amount for kids, does not harm them. This verdict would be wrong if someone found a federal rule requiring companies to keep safety studies on children's daily sugar intake.
Read the supporting source · www.law.cornell.edu ↗Quick answer & review status
Quick answer
Is it true that Food companies are legally responsible for having studies showing that the amount of sugar they recommend for daily use for children does not harm them?
No, not as stated. FDA itself has affirmed sucrose, ordinary cane or beet sugar, as generally recognized as safe by regulation. The rule allows it in food with no limit other than good manufacturing practice. Calley Means said it (matched by voice) on Joe Rogan Experience #2578 - Calley Means, aired Nov 6, 2026, at 1:57:32. The supporting source is law.cornell.edu, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.